Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 12/2017

13.06.2017 | Original Paper

3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy

verfasst von: Liang Yin, Hai-yan Xu, Sui-sheng Zheng, Ying Zhu, Jiang-xi Xiao, Wei Zhou, Si-si Yu, Liang-geng Gong

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to assess coronary microvascular dysfunction (CMD) differences in hypertrophic cardiomyopathy (HCM) patients using cardiac magnetic resonance (CMR) first-pass perfusion and late gadolinium enhancement imaging. Forty-seven patients with HCM and twenty-one healthy volunteers underwent CMR at rest. Imaging protocols included short axis cine, first-pass myocardial perfusion, and late gadolinium enhancement (LGE). Left ventricular end-diastolic wall thickness (EDTH), LGE, time to peak (Tpeak), maximal up-slope (Slopemax), and peak signal intensity (SIpeak) were assessed for each myocardial segment. The HCM myocardial segments were grouped by the degree of LGE and hypertrophy. Tpeak, SIpeak, Slopemax and EDTH in multiple groups were assessed and compared by ANOVA test/Kruskal–Wallis test. The Spearman correlation test was used to determine the relationships between EDTH, LGE and perfusion parameters (Tpeak, Slopemax and SIpeak). Compared to control group segments, Tpeak increased while Slopemax and SIpeak decreased in non-LGE/non-hypertrophic segments and LGE/hypertrophic segments in the HCM group, while Tpeak increased more significantly in LGE/hypertrophic segments (all p < 0.05). Tpeak statistically increased with increasing degrees of myocardial LGE (p < 0.01). Differences in Tpeak, SIpeak and EDTH were observed between segments with and without hypertrophy (p < 0.05). EDTH and LGE were positively correlated with Tpeak (r = 0.279, p = 0.031 and r = 0.237, p < 0.001). 3.0 T magnetic resonance myocardial perfusion imaging identifies abnormal perfusion in non-LGE and non-hypertrophic segments of HCM patients, and it may be helpful in the early diagnosis of coronary microvascular dysfunction in HCM. This abnormal perfusion is associated with the severity of myocardial fibrosis and the degree of hypertrophy.
Literatur
1.
2.
4.
Zurück zum Zitat Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ et al (2009) Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 54(3):250–254CrossRefPubMed Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ et al (2009) Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 54(3):250–254CrossRefPubMed
5.
Zurück zum Zitat Chiribiri A, Conte MR, Bonamini R, Gaita F, Nagel E (2011) Late gadolinium enhancement and sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol, 57(12):1402 (author reply 1402–1403)CrossRefPubMed Chiribiri A, Conte MR, Bonamini R, Gaita F, Nagel E (2011) Late gadolinium enhancement and sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol, 57(12):1402 (author reply 1402–1403)CrossRefPubMed
6.
Zurück zum Zitat Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA, Selvanayagam JB, Neubauer S, Watkins H (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115(18):2418–2425CrossRefPubMed Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA, Selvanayagam JB, Neubauer S, Watkins H (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115(18):2418–2425CrossRefPubMed
7.
Zurück zum Zitat Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J, Olivotto I, Rosen SD, Impallomeni M, Wijns W (1995) Effect of aging on myocardial perfusion reserve. J Nucl Med 36(11):2032–2036PubMed Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J, Olivotto I, Rosen SD, Impallomeni M, Wijns W (1995) Effect of aging on myocardial perfusion reserve. J Nucl Med 36(11):2032–2036PubMed
8.
Zurück zum Zitat Cortigiani L, Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E (2008) Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol 102(12):1718–1723CrossRefPubMed Cortigiani L, Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E (2008) Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy. Am J Cardiol 102(12):1718–1723CrossRefPubMed
9.
Zurück zum Zitat Porter TR, Xie F (2010) Myocardial perfusion imaging with contrast ultrasound. JACC Cardiovascular imaging 3(2):176–187CrossRefPubMed Porter TR, Xie F (2010) Myocardial perfusion imaging with contrast ultrasound. JACC Cardiovascular imaging 3(2):176–187CrossRefPubMed
10.
Zurück zum Zitat Li X, He S, Zhang YS, Chen Y, He JC (2016) Resting Myocardial contrast echocardiography for the evaluation of coronary microcirculation dysfunction in patients with early coronary artery disease. Clin Cardiol 39(8):453–458CrossRefPubMed Li X, He S, Zhang YS, Chen Y, He JC (2016) Resting Myocardial contrast echocardiography for the evaluation of coronary microcirculation dysfunction in patients with early coronary artery disease. Clin Cardiol 39(8):453–458CrossRefPubMed
11.
12.
Zurück zum Zitat Schindler TH, Schelbert HR, Quercioli A, Dilsizian V (2010) Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovascular imaging 3(6):623–640CrossRefPubMed Schindler TH, Schelbert HR, Quercioli A, Dilsizian V (2010) Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovascular imaging 3(6):623–640CrossRefPubMed
13.
Zurück zum Zitat Mohy-Ud-Din H, Lodge MA, Rahmim A (2015) Quantitative myocardial perfusion PET parametric imaging at the voxel-level. Phys Med Biol 60(15):6013–6037CrossRefPubMed Mohy-Ud-Din H, Lodge MA, Rahmim A (2015) Quantitative myocardial perfusion PET parametric imaging at the voxel-level. Phys Med Biol 60(15):6013–6037CrossRefPubMed
14.
Zurück zum Zitat Zhang YD, Li M, Qi L, Wu CJ, Wang X (2015) Hypertrophic cardiomyopathy: cardiac structural and microvascular abnormalities as evaluated with multi-parametric MRI. Eur J Radiol 84(8):1480–1486CrossRefPubMed Zhang YD, Li M, Qi L, Wu CJ, Wang X (2015) Hypertrophic cardiomyopathy: cardiac structural and microvascular abnormalities as evaluated with multi-parametric MRI. Eur J Radiol 84(8):1480–1486CrossRefPubMed
15.
Zurück zum Zitat Huang L, Han R, Ai T, Sun Z, Bai Y, Cao Z, Morelli JN, Xia L (2013) Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T. Clin Radiol 68(7):676–682CrossRefPubMed Huang L, Han R, Ai T, Sun Z, Bai Y, Cao Z, Morelli JN, Xia L (2013) Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T. Clin Radiol 68(7):676–682CrossRefPubMed
16.
Zurück zum Zitat Xu HY, Yang ZG, Sun JY, Wen LY, Zhang G, Zhang S, Guo YK (2014) The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance. Eur J Radiol 83(4):665–672CrossRefPubMed Xu HY, Yang ZG, Sun JY, Wen LY, Zhang G, Zhang S, Guo YK (2014) The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance. Eur J Radiol 83(4):665–672CrossRefPubMed
17.
Zurück zum Zitat Chiribiri A, Leuzzi S, Conte MR, Bongioanni S, Bratis K, Olivotti L, De Rosa C, Lardone E, Di Donna P, Villa AD et al (2015) Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death. Clin Radiol 70(5):495–501CrossRefPubMedPubMedCentral Chiribiri A, Leuzzi S, Conte MR, Bongioanni S, Bratis K, Olivotti L, De Rosa C, Lardone E, Di Donna P, Villa AD et al (2015) Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death. Clin Radiol 70(5):495–501CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat American College of Cardiology Foundation Task Force on Expert Consensus D, Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55(23):2614–2662CrossRef American College of Cardiology Foundation Task Force on Expert Consensus D, Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55(23):2614–2662CrossRef
19.
Zurück zum Zitat Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258(1):128–133CrossRefPubMed Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258(1):128–133CrossRefPubMed
20.
Zurück zum Zitat Barbosa CA, Castro CC, Avila LF, Parga Filho JR, Hattem DM, Fernandez EA (2009) Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups). Arq Bras Cardiol 426–433(4):418–425 Barbosa CA, Castro CC, Avila LF, Parga Filho JR, Hattem DM, Fernandez EA (2009) Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups). Arq Bras Cardiol 426–433(4):418–425
21.
Zurück zum Zitat Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349(11):1027–1035CrossRefPubMed Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349(11):1027–1035CrossRefPubMed
22.
Zurück zum Zitat Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31(8):988–998CrossRefPubMed Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31(8):988–998CrossRefPubMed
23.
Zurück zum Zitat Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41(9):1561–1567CrossRefPubMed Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41(9):1561–1567CrossRefPubMed
24.
Zurück zum Zitat Hussain ST, Chiribiri A, Morton G, Bettencourt N, Schuster A, Paul M, Perera D, Nagel E (2016) Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease. J Cardiovasc Magn Reson 18(1):44CrossRefPubMedPubMedCentral Hussain ST, Chiribiri A, Morton G, Bettencourt N, Schuster A, Paul M, Perera D, Nagel E (2016) Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease. J Cardiovasc Magn Reson 18(1):44CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Freed BH, Narang A, Bhave NM, Czobor P, Mor-Avi V, Zaran ER, Turner KM, Cavanaugh KP, Chandra S, Tanaka SM et al (2013) Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15:108CrossRefPubMedPubMedCentral Freed BH, Narang A, Bhave NM, Czobor P, Mor-Avi V, Zaran ER, Turner KM, Cavanaugh KP, Chandra S, Tanaka SM et al (2013) Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 15:108CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Larghat A, Biglands J, Maredia N, Greenwood JP, Ball SG, Jerosch-Herold M, Radjenovic A, Plein S (2012) Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance. Int J Cardiovasc Imaging 28(6):1499–1511CrossRefPubMed Larghat A, Biglands J, Maredia N, Greenwood JP, Ball SG, Jerosch-Herold M, Radjenovic A, Plein S (2012) Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance. Int J Cardiovasc Imaging 28(6):1499–1511CrossRefPubMed
27.
Zurück zum Zitat Papanastasiou G, Williams MC, Dweck MR, Alam S, Cooper A, Mirsadraee S, Newby DE, Semple SI (2016) Quantitative assessment of myocardial blood flow in coronary artery disease by cardiovascular magnetic resonance: comparison of Fermi and distributed parameter modeling against invasive methods. J Cardiovasc Magn Reson 18(1):57CrossRefPubMedPubMedCentral Papanastasiou G, Williams MC, Dweck MR, Alam S, Cooper A, Mirsadraee S, Newby DE, Semple SI (2016) Quantitative assessment of myocardial blood flow in coronary artery disease by cardiovascular magnetic resonance: comparison of Fermi and distributed parameter modeling against invasive methods. J Cardiovasc Magn Reson 18(1):57CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Patel AR, Antkowiak PF, Nandalur KR, West AM, Salerno M, Arora V, Christopher J, Epstein FH, Kramer CM (2010) Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol 56(7):561–569CrossRefPubMedPubMedCentral Patel AR, Antkowiak PF, Nandalur KR, West AM, Salerno M, Arora V, Christopher J, Epstein FH, Kramer CM (2010) Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol 56(7):561–569CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E (2000) Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101(12):1379–1383CrossRefPubMed Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E (2000) Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101(12):1379–1383CrossRefPubMed
30.
Zurück zum Zitat Sipola P, Lauerma K, Husso-Saastamoinen M, Kuikka JT, Vanninen E, Laitinen T, Manninen H, Niemi P, Peuhkurinen K, Jaaskelainen P et al (2003) First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology 226(1):129–137CrossRefPubMed Sipola P, Lauerma K, Husso-Saastamoinen M, Kuikka JT, Vanninen E, Laitinen T, Manninen H, Niemi P, Peuhkurinen K, Jaaskelainen P et al (2003) First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology 226(1):129–137CrossRefPubMed
31.
Zurück zum Zitat Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130(6):484–495CrossRefPubMed Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130(6):484–495CrossRefPubMed
32.
Zurück zum Zitat Chen X, Hu H, Qian Y, Shu J (2014) Relation of late gadolinium enhancement in cardiac magnetic resonance on the diastolic volume recovery of left ventricle with hypertrophic cardiomyopathy. J Thorac Dis 6(7):988–994PubMedPubMedCentral Chen X, Hu H, Qian Y, Shu J (2014) Relation of late gadolinium enhancement in cardiac magnetic resonance on the diastolic volume recovery of left ventricle with hypertrophic cardiomyopathy. J Thorac Dis 6(7):988–994PubMedPubMedCentral
33.
Zurück zum Zitat O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):867–874CrossRefPubMed O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):867–874CrossRefPubMed
34.
Zurück zum Zitat Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW et al (2015) Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy. Heart 101(11):870–876CrossRefPubMed Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW et al (2015) Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy. Heart 101(11):870–876CrossRefPubMed
35.
Zurück zum Zitat Lu M, Zhao S, Yin G, Jiang S, Zhao T, Chen X, Tian L, Zhang Y, Wei Y, Liu Q et al (2013) T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: a preliminary study. Eur J Radiol 82(5):e225–e231CrossRefPubMed Lu M, Zhao S, Yin G, Jiang S, Zhao T, Chen X, Tian L, Zhang Y, Wei Y, Liu Q et al (2013) T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: a preliminary study. Eur J Radiol 82(5):e225–e231CrossRefPubMed
36.
Zurück zum Zitat Matoh F, Satoh H, Shiraki K, Saitoh T, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H (2007) Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Fail 13(5):372–379CrossRefPubMed Matoh F, Satoh H, Shiraki K, Saitoh T, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H (2007) Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Fail 13(5):372–379CrossRefPubMed
37.
Zurück zum Zitat Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40(12):2156–2164CrossRefPubMed Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40(12):2156–2164CrossRefPubMed
38.
Zurück zum Zitat Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26(15):1461–1474CrossRefPubMed Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26(15):1461–1474CrossRefPubMed
39.
Zurück zum Zitat Tyan CC, Armstrong S, Scholl D, Stirrat J, Blackwood K, El-Sherif O, Thompson T, Wisenberg G, Prato FS, So A et al (2013) Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-Tesla magnetic resonance imaging. Circ Cardiovasc Imaging 6(2):229–238CrossRefPubMed Tyan CC, Armstrong S, Scholl D, Stirrat J, Blackwood K, El-Sherif O, Thompson T, Wisenberg G, Prato FS, So A et al (2013) Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-Tesla magnetic resonance imaging. Circ Cardiovasc Imaging 6(2):229–238CrossRefPubMed
40.
Zurück zum Zitat Ismail TF, Hsu LY, Greve AM, Goncalves C, Jabbour A, Gulati A, Hewins B, Mistry N, Wage R, Roughton M et al (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy: a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16:49CrossRefPubMedPubMedCentral Ismail TF, Hsu LY, Greve AM, Goncalves C, Jabbour A, Gulati A, Hewins B, Mistry N, Wage R, Roughton M et al (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy: a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16:49CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Gupta V, Kirisli HA, Hendriks EA, van der Geest RJ, van de Giessen M, Niessen W, Reiber JH, Lelieveldt BP (2012) Cardiac MR perfusion image processing techniques: a survey. Med Image Anal 16(4):767–785CrossRefPubMed Gupta V, Kirisli HA, Hendriks EA, van der Geest RJ, van de Giessen M, Niessen W, Reiber JH, Lelieveldt BP (2012) Cardiac MR perfusion image processing techniques: a survey. Med Image Anal 16(4):767–785CrossRefPubMed
43.
Zurück zum Zitat Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108(4):432–437CrossRefPubMed Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108(4):432–437CrossRefPubMed
44.
Zurück zum Zitat Soler R, Rodriguez E, Monserrat L, Mendez C, Martinez C (2006) Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function. J Comput Assist Tomogr 30(3):412–420CrossRefPubMed Soler R, Rodriguez E, Monserrat L, Mendez C, Martinez C (2006) Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function. J Comput Assist Tomogr 30(3):412–420CrossRefPubMed
45.
Zurück zum Zitat Melacini P, Corbetti F, Calore C, Pescatore V, Smaniotto G, Pavei A, Bobbo F, Cacciavillani L, Iliceto S (2008) Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. Int J Cardiol 128(3):364–373CrossRefPubMed Melacini P, Corbetti F, Calore C, Pescatore V, Smaniotto G, Pavei A, Bobbo F, Cacciavillani L, Iliceto S (2008) Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. Int J Cardiol 128(3):364–373CrossRefPubMed
46.
Zurück zum Zitat Aletras AH, Tilak GS, Hsu LY, Arai AE (2011) Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps. Circ Cardiovasc Imaging 4(4):425–434CrossRefPubMedPubMedCentral Aletras AH, Tilak GS, Hsu LY, Arai AE (2011) Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps. Circ Cardiovasc Imaging 4(4):425–434CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47(5):1043–1048CrossRefPubMed Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47(5):1043–1048CrossRefPubMed
48.
Zurück zum Zitat Krams R, Kofflard MJ, Duncker DJ, Von Birgelen C, Carlier S, Kliffen M, ten Cate FJ, Serruys PW (1998) Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 97(3):230–233CrossRefPubMed Krams R, Kofflard MJ, Duncker DJ, Von Birgelen C, Carlier S, Kliffen M, ten Cate FJ, Serruys PW (1998) Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 97(3):230–233CrossRefPubMed
49.
Zurück zum Zitat Villa AD, Sammut E, Zarinabad N, Carr-White G, Lee J, Bettencourt N, Razavi R, Nagel E, Chiribiri A (2016) Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson 18:4CrossRefPubMedPubMedCentral Villa AD, Sammut E, Zarinabad N, Carr-White G, Lee J, Bettencourt N, Razavi R, Nagel E, Chiribiri A (2016) Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson 18:4CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Jablonowski R, Fernlund E, Aletras AH, Engblom H, Heiberg E, Liuba P, Arheden H, Carlsson M (2015) Regional stress-induced ischemia in non-fibrotic hypertrophied myocardium in young HCM patients. Pediatr Cardiol 36(8):1662–1669CrossRefPubMedPubMedCentral Jablonowski R, Fernlund E, Aletras AH, Engblom H, Heiberg E, Liuba P, Arheden H, Carlsson M (2015) Regional stress-induced ischemia in non-fibrotic hypertrophied myocardium in young HCM patients. Pediatr Cardiol 36(8):1662–1669CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57(8):891–903CrossRefPubMed Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57(8):891–903CrossRefPubMed
52.
Zurück zum Zitat Brouwer WP, Baars EN, Germans T, de Boer K, Beek AM, van der Velden J, van Rossum AC, Hofman MB (2014) In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16:28CrossRefPubMedPubMedCentral Brouwer WP, Baars EN, Germans T, de Boer K, Beek AM, van der Velden J, van Rossum AC, Hofman MB (2014) In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16:28CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Hussain T, Dragulescu A, Benson L, Yoo SJ, Meng H, Windram J, Wong D, Greiser A, Friedberg M, Mertens L et al (2015) Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy. Pediatr Cardiol 36(5):970–978CrossRefPubMed Hussain T, Dragulescu A, Benson L, Yoo SJ, Meng H, Windram J, Wong D, Greiser A, Friedberg M, Mertens L et al (2015) Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy. Pediatr Cardiol 36(5):970–978CrossRefPubMed
Metadaten
Titel
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy
verfasst von
Liang Yin
Hai-yan Xu
Sui-sheng Zheng
Ying Zhu
Jiang-xi Xiao
Wei Zhou
Si-si Yu
Liang-geng Gong
Publikationsdatum
13.06.2017
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 12/2017
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-017-1189-9

Weitere Artikel der Ausgabe 12/2017

The International Journal of Cardiovascular Imaging 12/2017 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.